|
It was reported that the patient underwent a strabismus surgery on (b)(6) 2020 and the suture was used.After the surgery, the patient experienced discomfort including yellowing of the eyeballs.There was no suture deficiency noted before or during use.Post op examination showed increased inflammatory response.Vigamox ophthalmic drops, lotemax ophthalmic gel and/or prednisone forte 1% ophthalmic drops were used to treat the inflammatory response.There was no surgical intervention performed.Additional information has been requested.
|
|
Date sent to the fda: 12/29/2020.Additional information was requested, and the following was obtained: please provide additional information for each file/procedure/patient: the patient demographic info: age, gender, weight, bmi at the time of index procedure? i don¿t have the records to complete this.On what tissue was the suture used? strabismus surgery is rectus muscles and conjunctiva, pterygium is conjunctiva.What was the tissue condition, i.E., normal or thin, calcified, fragile, diseased? normal were there any pre-existing signs/symptoms of active inflammation/infection prior to this surgical procedure? no.Onset date of current symptoms from the time of index surgery? variable, usually 1-3 days after surgery.Other relevant patient factors/comorbidities/concomitant medications? none does the surgeon believe the suture causes ¿yellowing of the eyeballs¿? this yellowing is the inflammatory reaction around the sutures, not the sclera itself.What is physician¿s opinion as to the etiology of or contributing factors to this event (discomfort and inflammatory response)? i believe it has something to do with the suture listed above as it has not recurred after switching boxes.What is the patient¿s current status? patients are all doing well after extended anti-inflammatory drops.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|